CEPR researches how US government-granted monopolies of patents, copyrights, and other forms of intellectual property redistribute income upward and the role of digital global trade and international commercial agreements on inequality and economic mobility.
CEPR investiga cómo los monopolios de patentes, derechos de autor y otras formas de propiedad intelectual otorgados por el gobierno de los Estados Unidos redistribuyen el ingreso hacia arriba. CEPR analiza el papel del comercio mundial digital y los acuerdos comerciales internacionales sobre desigualdad y movilidad económica.
CEPR researches how US government-granted monopolies of patents, copyrights, and other forms of intellectual property redistribute income upward and the role of digital global trade and international commercial agreements on inequality and economic mobility.
CEPR investiga cómo los monopolios de patentes, derechos de autor y otras formas de propiedad intelectual otorgados por el gobierno de los Estados Unidos redistribuyen el ingreso hacia arriba. CEPR analiza el papel del comercio mundial digital y los acuerdos comerciales internacionales sobre desigualdad y movilidad económica.
· Op-Ed/Commentary
COVID-19GovernmentIntellectual PropertyUnited States Getting Beyond Trump’s Coronavirus Clown ShowDean Baker / TRUTHOUT / March 02, 2020
· Op-Ed/Commentary
Globalization and TradeIntellectual PropertyUnited States American Consumers Are Paying for Trump’s TariffsDean Baker / INSIDE SOURCES / February 20, 2020
· Op-Ed/Commentary
Health and Social ProgramsIntellectual PropertyUnited States Government-Granted Patent Monopolies Are Driving Up Drug PricesDean Baker / September 09, 2019
· Op-Ed/Commentary
GovernmentIntellectual PropertyUnited States Rigged: How Globalization and the Rules of the Modern Economy Were Structured to Make the Rich RicherDean Baker / September 08, 2019
· Op-Ed/Commentary
Globalization and TradeIntellectual PropertyWall Street China Did Not Trick the US — Trade Negotiators Served Corporate InterestsDean Baker / August 19, 2019
· Op-Ed/Commentary
GovernmentIntellectual PropertyUnited States Why Aren’t Democrats Talking About Ending Patent-Financed Drug Research?Dean Baker / July 02, 2019
· Op-Ed/Commentary
Health and Social ProgramsIntellectual PropertyUnited States Replace Patent Monopolies With Direct Public Funding for Drug ResearchDean Baker / July 01, 2019
· Op-Ed/Commentary
Affordable Care ActGovernmentIntellectual PropertyUnited States Would a Compromise on the Drug Pricing Bill Be a Victory or Defeat?Dean Baker / June 03, 2019
· Op-Ed/Commentary
Intellectual PropertyPrivate EquityUnited StatesWall Street Can Writers Guild Members Rewrite Private Equity’s Greedy Script?Eileen Appelbaum / April 19, 2019
· report
GovernmentIntellectual PropertyUnited States The Future of the Pharmaceutical Industry: Beyond Government-Granted MonopoliesDean Baker / March 06, 2019
